View cart “AZZALURE 10 Speyw.E./0,05 мл Plv.z.Her.e.Eng.-Lsg. (Clostridium botulinum),1, AZZALURE 10 Speyw.E./0,05 ml Plv.z.Her.e.Inj.-Lsg. (Clostridium botulinum), 1 (Kohlpharma GmbH)” has been added to your cart.
Outpatient treatment of patients with multiple sclerosis (to reduce the frequency and severity of exacerbations and slow the progression of disability).
Outpatient treatment of patients with multiple sclerosis (to reduce the frequency and severity of exacerbations and slow the progression of disability).
Outpatient treatment of patients with multiple sclerosis (to reduce the frequency and severity of exacerbations and slow the progression of disability).